CMG Launches DataLab™ MCP Server to Bring ECM Data Into AI Workflows | Read the Announcement

Meta Makes the Month, Healthcare Fills the Calendar

22 U.S. offerings raised $33.4B in October. That’s the lowest monthly deal count since April 2025, with proceeds up 120.2% year over year.

TL;DR

  • Fewer deals, bigger dollars: 22 U.S. offerings raised $33.4B in October, the lowest monthly count since April 2025, yet +120.2% in proceeds compared to October 2025’s $14.9B. 
  • Meta anchors the month: Meta’s $25.0B marketed follow-on accounted for 74.9% of October proceeds, extending the concentration theme set by Intel’s $20.0B print in August. 
  • Healthcare owns the IPO window: The sector led by count with 14 of 22 offerings, including all six IPOs ($1.1B) and eight follow-ons ($2.3B). 
  • Day-one performance holds: Healthcare IPOs traded up 26.8% on a dollar-weighted basis, in line with the sector’s 27.9% YTD and ahead of the 19.0% all-sector IPO average. Lycia Therapeutics led at +66.7%.
  • New In DataLab: CMG now tracks PIPEs and registered directs. 20 transactions above $50M settled in October for $7.5B. 

Fewer Deals, Bigger Dollars 

October was thin on count and heavy on capital. Twenty-two offerings priced in the U.S., the fewest in a single month since April 2025, when just 11 deals came to market. Those 22 offerings raised $33.4 billion in total gross proceeds ($33.0 billion base). That is more than double the $14.9 billion raised across 47 offerings in October 2025. 

 

Meta Anchors the Month 

In August, Intel’s $20.0 billion marketed follow-on dominated the tape. In October, the concentration theme intensified. Meta raised $25.0 billion through a marketed follow-on on October 26, which was 74.9% of the month’s total proceeds. Without Meta, the remaining 21 offerings raised $8.4 billion. 

Meta launched and priced in a single day, was upsized by 11%, and represented 1.8% of pre-offering market cap. It also included a forward component and launched alongside a concurrent convertible offering.  

 

Healthcare Spotlight: Owning the IPO Window 

Healthcare led October by count, with 14 of the 22 offerings. Every IPO that priced in October came from the sector: six deals raising $1.1 billion (base). Eight healthcare follow-ons added another $2.3 billion (base). Six IPOs made October the sector’s busiest IPO month of 2026, and it pushed year-to-date healthcare IPO proceeds past $10 billion ($10.3 billion across 33 deals). 

Performance held up. October’s six healthcare IPOs traded up 26.8% on a dollar-weighted day-one basis. That is in line with the sector’s 27.9% YTD and well ahead of the 19.0% YTD average for IPOs across all sectors. Healthcare IPOs have posted positive dollar-weighted day-one returns in eight of ten months this year. 

YTD gross proceeds

$10.3B

IPOs priced

33

$-weighted 1-day return

+27.9%

Simple avg 1-day

+23.4%

us healthcare ipos 2026 proceeds vs 1day return
Source: CMG DataLab. U.S.-listed healthcare IPOs priced 1/1/26–10/31/26 (excl. SPACs, direct listings). Proceeds include over-allotment. Return = offer to day-1 close, weighted by gross proceeds.

Lycia leads, and carries the average.

Lycia Therapeutics was October’s standout debut. It opened +58.6%, closed day one +66.7%, and was still +60.0% on day 14. The exercise of 2,646,000 over-allotment shares brought the total raise to $365.1 million. The month’s headline return rests heavily on that one deal, though. Without Lycia, October’s dollar-weighted day-one return falls to 9.2%. The concentration theme applies inside healthcare as well as across the broader landscape. 

Now in DataLab: PIPEs & Registered Directs 

CMG now tracks PIPEs and registered directs in DataLab, which adds a view of private and direct capital formation alongside public issuance.

In October, 20 transactions above $50 million priced, totaling $7.5 billion. For a full YTD breakdown, see our U.S. PIPEs & Registered Directs Market Overview and US Healthcare PIPEs Market Overview. To learn more, contact us. 

By Marcus Mlinarević

Contact [email protected] to request a demo.

This information provided is for informational purposes only, and should not be construed as legal, tax, investment, financial, or other advice. You should not act or refrain from acting on the basis of any of this information. Past performance is no guarantee of future results. CMG shall have no liability whatsoever for your use of this information.

Sign Up for Updates

Get the latest news and insights from CMG.

Leverage the CMG Network

Leading financial institutions rely on CMG to manage their ECM business. Get in touch to learn how CMG can help your business, too.